Yeshiva University: Montefiore and Einstein Begin Clinical Trial for Severely Ill Covid-19 Patients
April 04, 2020
April 04, 2020
BRONX, New York, April 4 [TNSmedicalresearch] -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
Montefiore Health System and Albert Einstein College of Medicine has started treating very sick COVID-19 patients as part of a multicenter trial evaluating a potential therapy for the new disease. The double-blind, placebo-controlled trial is testing whether sarilumab, a drug already approved for treating rheumatoid arthritis, can halt the infl . . .
Montefiore Health System and Albert Einstein College of Medicine has started treating very sick COVID-19 patients as part of a multicenter trial evaluating a potential therapy for the new disease. The double-blind, placebo-controlled trial is testing whether sarilumab, a drug already approved for treating rheumatoid arthritis, can halt the infl . . .